Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis

Condition:   Recurrent Respiratory PapillomatosisInterventions:   Drug: celebrex (celecoxib);   Drug: placebo capsulesSponsors:   North Shore Long Island Jewish Health System;   National Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruiting - verified January 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials